Join Our Crew

Join Our Ensemble of Star Performers

Cabaletta Bio’s platform is built on proven chimeric antigen receptor T cell (CAR T) technology, and we are leaders in employing engineered T cells to treat patients with serious autoimmune diseases. We offer competitive pay, benefits, and the chance to work as part of a fast-paced team at the forefront of cell therapy for autoimmune diseases. Is this music to your ears? Join our team!

Culture & Community Engagement: get REAL

Our Culture & Community Engagement Initiative
Cabaletta Bio is proud to be recognized as a Great Place to Work

Open Positions

Equal Opportunity Employer

Cabaletta Bio is an equal opportunity employer. We do not discriminate on the basis of race, color, gender, gender identity, sexual orientation, age, religion, national or ethnic origin, disability, protected veteran status or any other basis protected by applicable law.

Medical Director/Senior Director, Clinical Development

Philadelphia, PA

Medical Director/Senior Director, Clinical Development: Tell Me More

Research Associate/Sr. Research Associate, Molecular Biology

Philadelphia, PA

Research Associate/Sr. Research Associate, Molecular Biology

:
Tell Me More

Scientist/Senior Scientist, Computational Biology

Philadelphia, PA

Scientist/Senior Scientist, Computational Biology

:
Tell Me More

In House Clinical Research Associate (Remote)

Philadelphia, PA

In House Clinical Research Associate (Remote)

:
Tell Me More

Sr. Manager, Clinical Operations (Remote)

Philadelphia, PA

Sr. Manager, Clinical Operations (Remote)

:
Tell Me More

Research Associate/Senior Research Associate, Analytical Development

Philadelphia, PA

Research Associate/Senior Research Associate, Analytical Development

:
Tell Me More

Corporate Paralegal

Philadelphia, PA

Corporate Paralegal

:
Tell Me More

About Cabaletta Bio

Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases. The CABA™ platform encompasses two strategies: the CARTA (chimeric antigen receptor T cells for autoimmunity) strategy, with CABA-201, a 4-1BB-containing fully human CD19-CAR T, as the lead product candidate being evaluated in systemic lupus erythematosus and myositis, and the CAART (chimeric autoantibody receptor T cells) strategy, with multiple clinical-stage candidates, including DSG3-CAART for mucosal pemphigus vulgaris and MuSK-CAART for MuSK myasthenia gravis. The expanding CABA™ platform is designed to develop potentially curative therapies that offer deep and durable responses for patients with a broad range of autoimmune diseases. Cabaletta Bio’s headquarters and labs are located in Philadelphia, PA.

Uniquely Differentiated. Rapid. Elegant.

At Cabaletta, we are driven by the shared mission of developing a new type of therapy, where patients’ own cells are used to fight disease. We are building a culture grounded in the knowledge that success in the Cabaletta mission lies in the hands of individuals across every aspect of the company. To nurture this, we make an active commitment to the well-being and continuous growth of each person who joins our team. In this way, we are not only working to improve the lives of patients, but of everyone involved. #CabalettaCrew

Our Vision

To develop and launch the first targeted cellular therapies for patients with autoimmune diseases. When we succeed, we will be:

  • Champions to patients
  • Valued partners to physicians
  • Preferred collaborators to scientists and partners
  • Family to each other
  • Value-added providers to payors
  • Trusted, transparent, and reliably providing a fair return to our investors

Our Values

  • Prioritize the patient
  • Listen to the data
  • Serve the team
  • Improve every day
  • Pursue excellence and persevere
  • Be authentic, vulnerable, and courageous
  • Embrace differences, demand equity and inspire trust
  • Do the right thing